Eyebright Medical Technology (Beijing) (SHA:688050) obtained market registration approval from China's medical products administrator for its extended depth of focus intraocular lens.
The product is intended for vision correction after adult cataract surgery, according to a filing with the Shanghai bourse.
Shares of the medical device manufacturer closed 2% higher Monday.